Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 6 de 6
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Thromb Haemost ; 105(5): 883-91, 2011 May.
Artigo em Inglês | MEDLINE | ID: mdl-21359408

RESUMO

Percutaneous coronary intervention (PCI) represents the most important treatment of coronary artery stenosis today. But instent restenosis (ISR) is a limitation for the outcome. Fas and Fas Ligand have been implicated in apoptosis and vessel wall inflammation. Their role in ISR is not known so far. In this prospective study we studied 137 patients with stable coronary artery disease who underwent elective PCI. Blood samples were taken directly before and 24 hours after PCI. Soluble (s)Fas and sFas Ligand serum levels were measured by ELISA. Restenosis was evaluated six to eight months later either by coronary angiography or by exercise testing. During the follow-up period, 18 patients (13%) developed ISR. At baseline, patients with ISR had significantly lower median sFas, as well as sFas Ligand levels compared to patients without ISR (sFAS: ISR 492 pg/ml, no ISR 967 pg/ml, p=0.014; sFAS Ligand: ISR: 26 pg/ml, no ISR: 42 pg/ml, p=0.001). After PCI median sFas levels significantly decreased in patients with ISR compared to patients without ISR [ISR: -152 pg/ml (IQR -36 to -227), no ISR: -38 pg/ml (IQR -173 to +150 pg/ml), p=0.03]. sFas Ligand levels after PCI significantly increased in ISR patients compared to patients without ISR [ISR: 14 pg/ml (IQR -3 to +26 pg/ml), no ISR -6 pg/ml (IQR -22 to +21 pg/ml), p=0.014]. In conclusion, sFas and sFas Ligand seem to be associated with the development of ISR. Determination of serum levels before and after PCI might help identifying patients at higher risk of ISR.


Assuntos
Angioplastia , Doença das Coronárias/terapia , Reestenose Coronária/diagnóstico , Complicações Pós-Operatórias , Idoso , Biomarcadores/sangue , Angiografia Coronária , Reestenose Coronária/etiologia , Proteína Ligante Fas/sangue , Feminino , Seguimentos , Humanos , Masculino , Pessoa de Meia-Idade , Prognóstico , Stents/efeitos adversos , Receptor fas/sangue
2.
J Thromb Haemost ; 6(3): 508-13, 2008 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-18182031

RESUMO

BACKGROUND: We tested the hypothesis that plasma levels of plasminogen activator inhibitor-1 (PAI-1) are influenced by percutaneous coronary intervention (PCI) with the implantation of drug eluting stents (DES) and are able to predict the occurrence of in-stent restenosis (ISR). METHODS AND RESULTS: PAI-1 active antigen plasma levels were determined in 75 patients before and 24 h after PCI with DES implantation. Patients with ISR after six to eight months (16%) showed significantly lower PAI-1 plasma levels before PCI (ISR, 11.7 +/- 8.1 ng mL(-1); non-ISR, 22.8 +/- 18.8 ng mL(-1); P <0.05). PAI-1 levels in the lowest tertile were associated with a 9.5-fold increased risk of ISR, independent of clinical risk factors, angiographic or procedural characteristics, compared to the highest tertile (P < 0.05). The induced change of PAI-1 active antigen 24 h after PCI was significantly higher in patients with ISR (ISR, +5.6 +/- 8.0 ng mL(-1); non-ISR, -3.2 +/- 12.1 ng mL(-1); P < 0.05) with positive correlation to late lumen loss (r = 0.30; P < 0.05). CONCLUSIONS: ISR after DES implantation is significantly related to plasma levels of PAI-1 active antigen before and after PCI. If confirmed by larger multicenter studies, the determination of PAI-1 plasma levels might be clinically helpful in the identification of patients at high risk of developing of ISR, even after DES implantation.


Assuntos
Reestenose Coronária/sangue , Reestenose Coronária/prevenção & controle , Stents Farmacológicos/efeitos adversos , Inibidor 1 de Ativador de Plasminogênio/sangue , Idoso , Angiografia/métodos , Clopidogrel , Feminino , Humanos , Masculino , Pessoa de Meia-Idade , Análise de Regressão , Fatores de Risco , Ticlopidina/análogos & derivados , Ticlopidina/farmacologia , Fatores de Tempo , Ativador de Plasminogênio Tecidual/sangue , Resultado do Tratamento
3.
Eur J Gynaecol Oncol ; 27(6): 632-3, 2006.
Artigo em Inglês | MEDLINE | ID: mdl-17290602

RESUMO

Angiokeratomas are rare benign dermal lesions of the external genital system and occur before the age of 50 years. Four cases of angiokeratoma of the vulva diagnosed at our institution in a ten-year-period are reported and issues of the differential diagnosis are discussed.


Assuntos
Angioceratoma/patologia , Neoplasias Cutâneas/patologia , Doenças da Vulva/patologia , Adulto , Angioceratoma/diagnóstico , Diagnóstico Diferencial , Feminino , Histocitoquímica , Humanos , Pessoa de Meia-Idade , Neoplasias Cutâneas/diagnóstico , Doenças da Vulva/diagnóstico
4.
Eur J Gynaecol Oncol ; 26(4): 446-8, 2005.
Artigo em Inglês | MEDLINE | ID: mdl-16122200

RESUMO

AIM: To present the classification and diagnostic problems encountered between teratomas and other ovarian tumors as well as with other benign entities diagnosed and treated in our institution. METHODS: We analysed retrospectively the clinical and pathological characteristics of 87 teratomas examined in our hospital during the last ten years. RESULTS: Teratomas constituted 5% of all ovarian tumors. The age range was from 11-69 years old (median: 35). The most frequent symptom was lower abdominal pain in 68% of patients. A pelvic mass was noted in 3% of cases. A pregnancy was present in 3% of patients. In ten cases the tumors were bilateral. Tumor size ranged from 1-16 cm in diameter (median: 7.17 cm). The treatment consisted of cystectomy in 66% of the cases, oophorectomy in 23% or hysterectomy with both adnexa in 11% of cases. Fifty-seven cases presented with a histological diagnosis of mature teratoma, biphasic or triphasic type, three cases with monodermal teratoma, ten cases with ovarian neoplasms of mixed type, 15 cases with epidermal cysts, and two cases with benign cysts. Malignant changes within the teratomas were seen in 5% cases. CONCLUSION: Teratomas are common ovarian tumors at any age, especially during the reproductive age, with a low rate of complications and malignant transformation. The treatment should be based on patient age, fertility status, tumor size, the cystic or solid nature of the tumor and bilaterality.


Assuntos
Neoplasias Ovarianas/diagnóstico , Complicações Neoplásicas na Gravidez/diagnóstico , Teratoma/diagnóstico , Adolescente , Adulto , Idoso , Feminino , Humanos , Pessoa de Meia-Idade , Neoplasias Ovarianas/classificação , Gravidez , Complicações Neoplásicas na Gravidez/classificação , Estudos Retrospectivos , Teratoma/classificação
5.
Pacing Clin Electrophysiol ; 24(7): 1076-81, 2001 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-11475822

RESUMO

In a substantial number of patients, AF recurs after successful electrical cardioversion. The purpose of this study was to investigate if the atrial arrhythmias recorded immediately after cardioversion are associated with the risk of recurrence of the arrhythmia and to compare the prognostic significance of this parameter with that of other established risk factors. In a series of 71 patients, the risk factors for recurrence of AF during the first year after successful electrical cardioversion were analyzed. A new parameter that was investigated was the frequency of atrial premature beats and the presence of runs of supraventricular tachycardia in the Holter recording started immediately after the cardioversion. Age, left atrial size, left ventricular systolic function, duration of the arrhythmia before cardioversion, underlying cardiac disease, or medication taken were not found to be predictive of recurrence of the arrhythmia. However, the natural logarithm of the number of atrial premature complexes per hour of the Holter recording in the 37 patients in whom AF recurred was higher compared to that of the 34 patients who maintained sinus rhythm (P < 0.0005). The same was true if only the first 6 hours of the recording were analyzed (P < 0.0005). There was a trend for more frequent arrhythmia recurrence if runs of supraventricular tachycardia were present. The finding of > 10 atrial premature complexes per hour in the recording had a relative risk of 2.57 (1.51-4.37), a positive predictive accuracy of 76.5%, and a negative predictive accuracy of 70.3% for subsequent arrhythmia recurrence. We can conclude that frequent (> 10/hour) atrial premature complexes in the Holter recording after electrical cardioversion for AF is a significant risk factor for recurrence of the arrhythmia.


Assuntos
Arritmias Cardíacas/epidemiologia , Fibrilação Atrial/terapia , Cardioversão Elétrica , Feminino , Humanos , Masculino , Pessoa de Meia-Idade , Prognóstico , Estudos Prospectivos , Recidiva , Fatores de Tempo
6.
Science ; 204(4400): 1415-7, 1979 Jun 29.
Artigo em Inglês | MEDLINE | ID: mdl-17814200

RESUMO

The scanning multichannel microwave radiometer results for the Gulf of Alaska Seasat Experiment Workshop are quite encouraging, especially in view of the immaturity of the data-processing algorithms. For open ocean, rain-free cells of highest-quality surface truth wind determinations exhibit standard deviations of 3 meters per second about a bias of 1.5 meters per second. The sea-surface temperature shows a standard deviation of approximately 1.5 degrees C about a bias of 3 degrees to 5 degrees C under a variety of changing meteorological conditions.

SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...